Ivan Gentile to Drug Design
This is a "connection" page, showing publications Ivan Gentile has written about Drug Design.
Connection Strength
0.018
-
NS5B polymerase inhibitors in phase II clinical trials for HCV infection. Expert Opin Investig Drugs. 2018 03; 27(3):243-250.
Score: 0.018
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.